Bharat Parenterals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 598.1 million compared to INR 819 million a year ago. Revenue was INR 624 million compared to INR 883.1 million a year ago. Net income was INR 35.2 million compared to INR 99.2 million a year ago. Basic earnings per share from continuing operations was INR 6.07 compared to INR 17.19 a year ago. Diluted earnings per share from continuing operations was INR 6.07 compared to INR 17.19 a year ago.
For the six months, sales was INR 1,297.2 million compared to INR 1,079.9 million a year ago. Revenue was INR 1,344.1 million compared to INR 1,150.4 million a year ago. Net income was INR 110.4 million compared to INR 111 million a year ago. Basic earnings per share from continuing operations was INR 19.1 compared to INR 19.22 a year ago. Diluted earnings per share from continuing operations was INR 19.1 compared to INR 19.22 a year ago.